ALEXANDER KERR: Open Payments
NPI 1275229023 · SEYMOUR, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 25 payments from 7 companies in 2025. Trend: 2023 $447 · 2024 $630 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $196 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Dexcom, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: Ozempic, CAPLYTA, GEMTESA, Wegovy, Rybelsus, SHINGRIX, GVOKE HYPOPEN, Dexcom G6 Transmitter.
Industry payments across TN — which companies pay providers there.
